Literature DB >> 3052109

Molecular biology of the renin-angiotensin system.

V J Dzau1, D W Burt, R E Pratt.   

Abstract

This paper reviews the molecular biology of the renin-angiotensin system. The renin gene structure is analyzed in detail, including an examination of the putative regulatory regions. The combined action of these regulatory sequences would result in the complex, tissue-specific expression and regulation observed in vivo. The expression of the tissue renin-angiotensin systems, which may have important physiological functions, is also described. In addition, the pathway of renin biosynthesis and secretion is reviewed. This includes speculation on the fate of circulating prorenin and the physiological role of multiple renin forms and secretory pathways. The molecular approaches described in this paper have greatly advanced our knowledge of the biology of the renin-angiotensin system. Future studies using these and other approaches should provide further insight into this complex system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3052109     DOI: 10.1152/ajprenal.1988.255.4.F563

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

1.  LXRalpha functions as a cAMP-responsive transcriptional regulator of gene expression.

Authors:  K Tamura; Y E Chen; M Horiuchi; Q Chen; L Daviet; Z Yang; M Lopez-Ilasaca; H Mu; R E Pratt; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

2.  Identification of a negative regulatory element involved in tissue-specific expression of mouse renin genes.

Authors:  G Barrett; M Horiuchi; M Paul; R E Pratt; N Nakamura; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

3.  High plasma prorenin in non diabetic siblings of non insulin-dependent diabetes mellitus patients.

Authors:  N Glorioso; C Troffa; G Tonolo; F Filigheddu; F Dettori; M Ciccarese; A Saller; A Soro; E Brocco; P Pinna-Parpaglia; F Mantero; P P Faronato; R Nosadini; M Maioli
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

4.  Elastase-2, an angiotensin II-generating enzyme, contributes to increased angiotensin II in resistance arteries of mice with myocardial infarction.

Authors:  Christiane Becari; Marcondes A B Silva; Marina T Durand; Cibele M Prado; Eduardo B Oliveira; Mauricio S Ribeiro; Helio C Salgado; Maria Cristina O Salgado; Rita C Tostes
Journal:  Br J Pharmacol       Date:  2017-04-05       Impact factor: 8.739

5.  Mechanism of cAMP regulation of renin gene transcription by proximal promoter.

Authors:  K Tamura; S Umemura; S Yamaguchi; T Iwamoto; S Kobayashi; A Fukamizu; K Murakami; M Ishii
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

6.  Distinct nuclear proteins competing for an overlapping sequence of cyclic adenosine monophosphate and negative regulatory elements regulate tissue-specific mouse renin gene expression.

Authors:  M Horiuchi; R E Pratt; N Nakamura; V J Dzau
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

7.  Novel and effective gene transfer technique for study of vascular renin angiotensin system.

Authors:  R Morishita; G H Gibbons; Y Kaneda; T Ogihara; V J Dzau
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

8.  Furosemide stimulates renin expression in the kidneys of salt-supplemented rats.

Authors:  B Modena; S Holmer; K U Eckardt; K Schricker; G Riegger; B Kaissling; A Kurtz
Journal:  Pflugers Arch       Date:  1993-09       Impact factor: 3.657

9.  Estrogen modulates ClC-2 chloride channel gene expression in rat kidney.

Authors:  Danielle S Nascimento; Carlos U Reis; Regina C Goldenberg; Tânia M Ortiga-Carvalho; Carmen C Pazos-Moura; Sandra E Guggino; William B Guggino; Marcelo M Morales
Journal:  Pflugers Arch       Date:  2003-06-17       Impact factor: 3.657

Review 10.  Clinical implications for therapy: possible cardioprotective effects of ACE inhibition.

Authors:  V J Dzau
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.